Comparison of 2 Algorithms for Adding Insulin Glargine (GLA) to Metformin (MET) in Patients (Pts) with T2DM

被引：0

|

作者：

Dailey, George

Traylor, Louise

Gill, Jasvinder

机构：

来源：

DIABETES | 2015年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1037-P

引用

收藏

页码：A266 / A266

页数：1

相关论文

共 50 条

[41] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
Shafie, Asrul Akmal
Ng, Chin Hui
[J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
[42] Less hypoglycemia with exenatide versus insulin glargine, despite similar Hba1c improvement, in patients with T2dm adjunctively treated with metformin
Trautmann, Michael
Burger, Jude
Johns, Don
Brodows, Robert
Okerson, Ted
Roberts, Anthony
Barnett, Anthony
[J]. DIABETES, 2007, 56 : A45 - A45
[43] Improved blood pressure (BP) lowering in hypertensive patients (pts) with type 2 diabetes (T2DM) with vildagliptin combined with metformin compared with metformin alone
Bosi, E.
Shao, Q.
Cohen, S. E.
[J]. DIABETES, 2007, 56 : A549 - A549
[44] OLDER PEOPLE WITH T2DM: GLYCEMIC CONTROL AND LESS HYPOGLYCEMIA WITH INSULIN GLARGINE 300 U/ML (GLA-300) VS GLA-100 AT 1 YEAR
Yale, J. F.
Trescoli, C.
Cahn, A.
Lee, M.
Brulle-Wohlhueter, C.
Chevalier, S.
Bolli, G. B.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A116 - A116
[45] Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy-104-Week VERTIS MET Trial
Gallo, Silvina
Charbonnel, Bernard
Goldman, Allison
Shi, Harry
Huyck, Susan
Darekar, Amanda
Lauring, Brett
Terra, Steven
[J]. DIABETES, 2018, 67
[46] METFORMIN INCREASES SURVIVAL IN T2DM PATIENTS WITH PANCREATIC CANCER AND LYMPHOMA
Vacheron, A.
Wynn, A.
Zuber, J.
Soloman, S.
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 624 - 625
[47] Effect of Lixisenatide vs. Liraglutide on Glycemic Control, Gastric Emptying, and Safety Parameters in Optimized Insulin Glargine T2DM ± Metformin
Meier, Juris
Rosenstock, Julio
Hincelin-Mery, Agnes
Royduval, Christine
Delfolie, Astrid
Coester, Hans-Veit
Forst, Thomas
Kapitza, Christoph
[J]. DIABETES, 2014, 63 : A262 - A262
[48] The incidence of myocardial infarction (MI) is lower among patients with type 2 diabetes mellitus (T2DM) receiving insulin glargine
[J]. Reactions Weekly, 2007, 1178 (1) : 2 - 2
[49] METFORMIN AND ITS EFFECT ON THYROID AND GI MALIGNANCY IN PATIENTS WITH T2DM
Branch, P.
Brannick, B.
Henderson, D.
Zuber, J.
Solomon, S.
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 633 - 633
[50] Metformin not independently associated with TSH levels in euthyroid patients with T2DM
[J]. Nature Reviews Endocrinology, 2012, 8 (9) : 508 - 508

← 1 2 3 4 5 →